Literature DB >> 18272666

Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Joseph Horzempa1, Thomas K Held, Alan S Cross, Dana Furst, Mohammed Qutyan, Alice N Neely, Peter Castric.   

Abstract

The O antigen is both a major structural outer membrane component and the dominant epitope of most gram-negative bacteria. Pseudomonas aeruginosa 1244 produces a type IV pilus and covalently links an O-antigen repeating unit to each pilin monomer. Here we show that immunization of mice with pure pilin from strain 1244 by use of either the mouse respiratory model or the thermal injury model resulted in protection from challenge with a pilus-null O-antigen-producing 1244 mutant. These results provide evidence that the pilin glycan stimulates a protective response that targets the O antigen, suggesting that this system could be used as the basis for the development of a variety of bioconjugate vaccines protective against gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272666      PMCID: PMC2292668          DOI: 10.1128/CVI.00476-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  46 in total

Review 1.  Prokaryotic glycosylation.

Authors:  C Schäffer; M Graninger; P Messner
Journal:  Proteomics       Date:  2001-02       Impact factor: 3.984

2.  Adhesion of Pseudomonas aeruginosa pilin-deficient mutants to mucin.

Authors:  R Ramphal; L Koo; K S Ishimoto; P A Totten; J C Lara; S Lory
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

3.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.

Authors:  J J Donnelly; R R Deck; M A Liu
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa.

Authors:  Adrian W Zuercher; Michael P Horn; Hong Wu; Zhijun Song; Cathrine J Bundgaard; Helle Krogh Johansen; Niels Høiby; Paul Marcus; Alois B Lang
Journal:  Vaccine       Date:  2006-03-20       Impact factor: 3.641

6.  Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses.

Authors:  P A Castric; C D Deal
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.

Authors:  P Anderson; M E Pichichero; R A Insel
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).

Authors:  R T Coughlin; W C Bogard
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

Review 9.  Protein glycosylation in bacterial mucosal pathogens.

Authors:  Christine M Szymanski; Brendan W Wren
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

10.  Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults.

Authors:  E Y Konadu; J C Parke; H T Tran; D A Bryla; J B Robbins; S C Szu
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 7.759

View more
  14 in total

Review 1.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species.

Authors:  Bente Børud; Finn Erik Aas; Ashild Vik; Hanne C Winther-Larsen; Wolfgang Egge-Jacobsen; Michael Koomey
Journal:  J Bacteriol       Date:  2010-04-02       Impact factor: 3.490

3.  Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244.

Authors:  Mohammed Qutyan; Matthew Henkel; Joseph Horzempa; Michael Quinn; Peter Castric
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

4.  Development of Rare Bacterial Monosaccharide Analogs for Metabolic Glycan Labeling in Pathogenic Bacteria.

Authors:  Emily L Clark; Madhu Emmadi; Katharine L Krupp; Ananda R Podilapu; Jennifer D Helble; Suvarn S Kulkarni; Danielle H Dube
Journal:  ACS Chem Biol       Date:  2016-10-28       Impact factor: 5.100

5.  Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation.

Authors:  Amirreza Faridmoayer; Messele A Fentabil; M Florencia Haurat; Wen Yi; Robert Woodward; Peng George Wang; Mario F Feldman
Journal:  J Biol Chem       Date:  2008-10-17       Impact factor: 5.157

Review 6.  Glycans in pathogenic bacteria--potential for targeted covalent therapeutics and imaging agents.

Authors:  Van N Tra; Danielle H Dube
Journal:  Chem Commun (Camb)       Date:  2014-05-11       Impact factor: 6.222

7.  Induction of Specific Humoral Immune Response in Mice against a Pseudomonas aeruginosa Chimeric PilQ/PilA Protein.

Authors:  Mehrdad Gholami; Alireza Salimi Chirani; Reza Falak; Mona Moshiri; Shabnam Razavi; Gholamreza Irajian
Journal:  Rep Biochem Mol Biol       Date:  2018-10

8.  Metabolic Glycan Labeling-Based Screen to Identify Bacterial Glycosylation Genes.

Authors:  Karen D Moulton; Adedunmola P Adewale; Hallie A Carol; Sage A Mikami; Danielle H Dube
Journal:  ACS Infect Dis       Date:  2020-11-13       Impact factor: 5.084

9.  Cromoglycate mesogen forms isodesmic assemblies promoted by peptides and induces aggregation of a range of proteins.

Authors:  Arizza Chiara S Ibanez; Elaine Marji; Yan-Yeung Luk
Journal:  RSC Adv       Date:  2018-08-21       Impact factor: 4.036

10.  Metabolic inhibitors of bacterial glycan biosynthesis.

Authors:  Daniel A Williams; Kabita Pradhan; Ankita Paul; Ilana R Olin; Owen T Tuck; Karen D Moulton; Suvarn S Kulkarni; Danielle H Dube
Journal:  Chem Sci       Date:  2020-01-08       Impact factor: 9.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.